Skip to main content
. 2017 Dec 4;8(66):110326–110336. doi: 10.18632/oncotarget.22887

Table 5. Stratified analyses between MTHFR rs3753584 T>C polymorphism and NSCLC risk by sex, age, BMI, smoking status and alcohol consumption.

Variable MTHFR rs3753584 T>C (case/control)a Adjusted ORb (95% CI); P
TT TC CC TT TC CC TC / CC CC vs. (TC/TT)
Sex
Male 231/450 52/127 4/10 1.00 0.80 (0.54–1.17);P: 0.242 0.68 (0.20–2.32);P: 0.533 0.78 (0.54–1.14);P: 0.201 0.71 (0.21–2.42);P: 0.578
Female 172/350 59/89 3/3 1.00 1.35 (0.92–1.97);P: 0.128 2.51 (0.479–12.75);P: 0.268 1.38 (0.95–2.01);P: 0.093 2.34 (0.46–11.88);P: 0.304
Age
< 60 181/362 54/110 3/3 1.00 0.95 (0.65–1.40);P: 0.806 1.30 (0.25–6.67);P: 0.756 0.96 (0.66–1.41);P: 0.848 1.31 (0.26–6.73);P: 0.745
≥ 60 222/438 57/106 4/10 1.00 1.12 (0.77–1.63);P: 0.560 0.89 (0.26–3.04);P: 0.855 1.10 (0.76–1.58);P: 0.610 0.87 (0.26–2.97);P: 0.827
Smoking status
Never 240/650 73/168 4/9 1.00 1.16 (0.84–1.60);P: 0.359 1.48 (0.44–5.00);P: 0.528 1.18 (0.86–1.61);P: 0.314 1.43 (0.43–4.83);P: 0.562
Ever 163/150 38/48 3/4 1.00 0.77 (0.47–1.25);P: 0.281 0.66 (0.14–3.02);P: 0.593 0.76 (0.47–1.21);P: 0.247 0.70 (0.15–3.20);P: 0.645
Alcohol consumption
Never 341/735 96/202 7/11 1.00 0.99 (0.74–1.32);P: 0.937 1.43 (0.52–3.92);P: 0.489 1.01 (0.76–1.33);P: 0.951 1.43 (0.52–3.92);P: 0.486
Ever 62/65 15/14 0/2 1.00 1.31 (0.56–3.07);P: 0.537 - 1.08 (0.48–2.45);P: 0.852 -
BMI (kg/m2)
< 24 265/432 69/105 3/9 1.00 1.04 (0.73–1.48);P: 0.830 0.47 (0.12–1.84);P: 0.278 0.99 (0.70–1.40);P: 0.960 0.47 (0.12–1.82);P: 0.272
≥ 24 138/368 42/111 4/4 1.00 0.99 (0.65–1.50);P: 0.946 3.34 (0.80–14.04);P: 0.100 1.06 (0.70–1.59);P: 0.788 3.35 (0.80–14.04);P: 0.098

a The genotyping was successful in 521 (100.00%) NSCLC cases, and 1030 (99.90%) controls for MTHFR rs3753584 T>C;

b Adjusted for age, sex, BMI, smoking status and alcohol consumption (besides stratified factors accordingly) in a logistic regression model;